March 23, 2022

Within3 on MAPS: How COVID improved value provision for medical affairs

The pandemic instantly changed how medical affairs organizations approached day-to-day work. As we enter year three, medical affairs leaders consider their longer-term strategy.
how medical affairs creates value

Medical affairs teams learned a great deal when the pandemic forced a mass shift to asynchronous virtual advisory boards or virtual 1:1 meetings rather than traditional in-person events. And while many of us will eagerly return to face-to-face congresses and other large-scale networking opportunities, the way we work is forever changed – as are the processes and opportunities around how medical affairs creates value within the broader organization.

On the MAPS Content Hub, Within3 Vice President, Medical Affairs Mike Abbadessa makes the case that insights generation and overall value provision for medical affairs actually increased as a result of pandemic-induced challenges and how medical affairs teams solved them. These changes primarily occurred within three distinct areas:

  • Support for diversity and inclusion across all aspects of key opinion leader engagement
  • Freedom to contribute to scientific discussion, without inconvenience due to travel or one-time-only web meetings
  • Increased access to a global community to draw perspective from a range of experiences

In a challenging business and scientific environment, virtual, asynchronous, and even hybrid engagement revealed efficiencies, accelerated timelines, improved insight generation, and opened opportunities for MSLs and medical affairs programs, opening the door for medical affairs teams to become a value center within their larger organization.

Read the article.

 

Related Posts:

pharma and women's health

Within3 in Journal of mHealth: how can pharma address gender inequality in healthcare?

Life science companies can use technology to correct drug development and healthcare inequalities.
virtual technology for medical congresses

Within3 in Journal of mHealth: Using virtual technology with live events

Virtual engagement won’t replace traditional congresses. But it will make them better.
virtual engagement

Medtech News on WFH, digital engagement, and remote trials with Within3

Lance Hill, CEO at Within3, and Richard Warren outline how life sciences companies can be successful with remote clinical trials and other virtual engagements.